Patents by Inventor Nam Yu

Nam Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240166819
    Abstract: Provided herein are a sulfur copolymer derived from an elemental sulfur and a thiol monomer and a method for preparing the same. The sulfur copolymer is synthesized by a simple method, and can be widely used in cameras and lenses, or defense materials-related industries, by replacing expensive inorganic materials used in existing infrared lenses. In addition, by adjusting the content of one or more sulfur monomers or two or more sulfur monomers, not only mid-wave infrared transmission but also long-wave infrared transmittance can be maintained at a high level.
    Type: Application
    Filed: March 7, 2023
    Publication date: May 23, 2024
    Inventors: Miyeon LEE, Jaesang YU, Nam Ho YOU
  • Publication number: 20240168450
    Abstract: The present disclosure discloses a method of generating a master state that is a normal state in a repeated cycle by analyzing log data output from a programmable logic controller (PLC). In addition, a method of generating log data as graph data as data preprocessing for generating a master state is disclosed. The method of generating a master pattern and the method of training a cycle analysis model according to the present disclosure are different from the related art in that the methods are a technology of processing a machine control language (low-level language) that is difficult for humans to analyze and converting the machine control language into an analyzable language (high-level language), i.e., a machine language processing (MLP)-based technology that analyzes the executed machine language (a language that controls a machine) with a computer and can be understood by humans.
    Type: Application
    Filed: November 12, 2021
    Publication date: May 23, 2024
    Applicant: UDMTEK
    Inventors: Gi Nam Wang, Jun Pyo Park, Seung Woo Han, Kang Hee Han, Min Young Jung, Sang Chul Yoo, Geun Ho Yu
  • Patent number: 11980688
    Abstract: Provided are a nanoliposome-microbubble conjugate in which a drug for hair loss treatment such as finasteride, minoxidil, dutasteride, etc. is encapsulated in a nanoliposome and a composition for alleviating or treating hair loss containing the same. Since an orally administered agent such as finasteride, currently useful as a drug for hair loss treatment, causes side effects, drug delivery through scalp application is most desirable, but the drug is not delivered to hair follicle cells through scalp application alone. Since a drug for hair loss treatment useful as an external preparation for skin causes various side effects, the concentration thereof that is used needs to be further lowered. The above nanoliposome-microbubble conjugate is capable of increasing the delivery efficiency of a drug for hair loss treatment at a low concentration, and is thus very effective at treating androgenic alopecia.
    Type: Grant
    Filed: October 20, 2021
    Date of Patent: May 14, 2024
    Assignee: MOOGENE MEDI CO., LTD.
    Inventor: Kyeong Nam Yu
  • Publication number: 20240116333
    Abstract: The present invention relates to a heater for an electric vehicle, including: a radiator disposed in the electric vehicle to radiate heat when power is supplied thereto; a power supply part disposed in the electric vehicle to supply the power to the radiator; and a controller for controlling the operation of the power supply part, wherein the radiator is made of a carbon material and emits far infrared light therefrom when the power is supplied from the power supply part thereto. According to the present invention, the radiator emits the far infrared light to enable the heat to be applied directly to a user's body, thereby reducing an amount of power consumed unnecessarily and providing high thermal comfort for the user.
    Type: Application
    Filed: October 26, 2022
    Publication date: April 11, 2024
    Applicant: EVERWELL TECHNOLOGY CO., LTD
    Inventor: Su Nam YU
  • Patent number: 11944705
    Abstract: Provided are a nanoliposome-microbubble conjugate in which a drug for hair loss treatment such as finasteride, minoxidil, dutasteride, etc. is encapsulated in a nanoliposome and a composition for alleviating or treating hair loss containing the same. Since an orally administered agent such as finasteride, currently useful as a drug for hair loss treatment, causes side effects, drug delivery through scalp application is most desirable, but the drug is not delivered to hair follicle cells through scalp application alone. Since a drug for hair loss treatment useful as an external preparation for skin causes various side effects, the concentration thereof that is used needs to be further lowered. The above nanoliposome-microbubble conjugate is capable of increasing the delivery efficiency of a drug for hair loss treatment at a low concentration, and is thus very effective at treating androgenic alopecia.
    Type: Grant
    Filed: October 20, 2021
    Date of Patent: April 2, 2024
    Assignee: MOOGENE MEDI CO., LTD.
    Inventor: Kyeong Nam Yu
  • Patent number: 11932362
    Abstract: A heat generation diving suit according to an embodiment of the present invention includes: a clothes unit made of a material having a waterproof function, and configured to cover at least a part of a user's body; a power transmission unit having a waterproof function, and configured to wirelessly transmit power of a battery unit; a power reception unit provided in the clothes unit, and configured to have a waterproof function, attach and detach the power transmission unit, and receive power wirelessly transmitted from the power transmission unit; and a heat generation unit configured to emit heat using the power supplied from the power reception unit.
    Type: Grant
    Filed: August 29, 2022
    Date of Patent: March 19, 2024
    Assignee: EVERWELL TECHNOLOGY CO., LTD
    Inventor: Su Nam Yu
  • Publication number: 20240088442
    Abstract: Provided are an electrolyte for a rechargeable lithium battery and a rechargeable lithium battery including the same, the electrolyte including a non-aqueous organic solvent, a lithium salt, and an additive, wherein the additive is a composition including a first compound, a second compound, and a third compound, the first compound is represented by Chemical Formula 1, the second compound is represented by Chemical Formula 2, and the third compound is a cyclic carbonate compound. Details of Chemical Formulas 1 and 2 are as described in the specification.
    Type: Application
    Filed: July 14, 2023
    Publication date: March 14, 2024
    Inventors: Tae Hyon BAE, Yunhee KIM, Sanghyung KIM, Seunghyeon SON, Harim LEE, Arum YU, Jeong-A LEE, Saehun KIM, Nam-Soon CHOI
  • Patent number: 11918599
    Abstract: The present invention relates to a composition for preventing or treating a neuroinflammatory disease, which can inhibit the expression of neuroinflammatory cytokines, promote the degradation of amyloid beta, and improve a cognitive function in an animal model of Alzheimer's disease. More specifically, the present invention relates to a composition for preventing or treating a neuroinflammatory disease comprising didanosine or a pharmaceutically acceptable salt thereof, and the composition may be used for the development of drugs and quasi-drug materials.
    Type: Grant
    Filed: October 18, 2022
    Date of Patent: March 5, 2024
    Assignees: Daegu Gyeongbuk Institute of Science and Technology, GliaCellTech Inc.
    Inventors: Seong-Woon Yu, Hyeri Nam, Younghwan Lee
  • Patent number: 11827696
    Abstract: The present invention relates to an immunogenic fragment peptide of an EN2 protein or an antibody composition specifically recognizing the same. In the present invention, EN2 protein can be quantified through a method of specifically recognizing the peptide. Also, an antibody prepared using the peptide has vastly superior detection sensitivity compared to existing EN2 protein antibodies and thus can be useful in a diagnostic agent for diagnosing prostate cancer.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: November 28, 2023
    Assignee: Sung Kyun Biotech Co., Ltd.
    Inventors: Kyeong-Nam Yu, Eun-Yi Cho, Seung-Hee Chang, Seon-Hee Kim, Hyun-Suk Kim, Ki-Moon Park
  • Patent number: 11766485
    Abstract: The present invention relates to a nanoliposome-microbubble conjugate, in which a complex of a Cas9 protein, a guide RNA inhibiting SRD5A2 gene expression and a cationic polymer is encapsulated in a nanoliposome, and to a composition for the amelioration or treatment of hair loss containing the same. Currently, drugs used for the treatment of hair loss cause serious side effects such as loss of libido or erectile dysfunction, and hair loss progresses again when drug treatment is stopped. However, when the nanoliposome-microbubble conjugate of the present invention is used, the expression of SRD5A2 inducing hair loss can be fundamentally suppressed, and the treatment of male hair loss can be performed very effectively.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: September 26, 2023
    Assignee: MOOGENE MEDI CO., LTD.
    Inventors: Jee-Yeon Ryu, Eun-Jeong Won, Han A Reum Lee, Kyeong-Nam Yu
  • Patent number: 11746146
    Abstract: The present invention relates to an immunogenic fragment peptide of an EN2 protein or an antibody composition specifically recognizing the same. In the present invention, EN2 protein can be quantified through a method of specifically recognizing the peptide. Also, an antibody prepared using the peptide has vastly superior detection sensitivity compared to existing EN2 protein antibodies and thus can be useful in a diagnostic agent for diagnosing prostate cancer.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: September 5, 2023
    Assignee: SUNG KYUN BIOTECH CO., LTD.
    Inventors: Kyeong-Nam Yu, Eun-Yi Cho, Seung-Hee Chang, Seon-Hee Kim, Hyun-Suk Kim, Ki-Moon Park
  • Patent number: 11732035
    Abstract: The present invention relates to an immunogenic fragment peptide of an EN2 protein or an antibody composition specifically recognizing the same. In the present invention, EN2 protein can be quantified through a method of specifically recognizing the peptide. Also, an antibody prepared using the peptide has vastly superior detection sensitivity compared to existing EN2 protein antibodies and thus can be useful in a diagnostic agent for diagnosing prostate cancer.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: August 22, 2023
    Assignee: Sung Kyun Biotech Co., Ltd.
    Inventors: Kyeong-Nam Yu, Eun-Yi Cho, Seung-Hee Chang, Seon-Hee Kim, Hyun-Suk Kim, Ki-Moon Park
  • Publication number: 20230083311
    Abstract: A heat generation diving suit according to an embodiment of the present invention includes: a clothes unit made of a material having a waterproof function, and configured to cover at least a part of a user's body; a power transmission unit having a waterproof function, and configured to wirelessly transmit power of a battery unit; a power reception unit provided in the clothes unit, and configured to have a waterproof function, attach and detach the power transmission unit, and receive power wirelessly transmitted from the power transmission unit; and a heat generation unit configured to emit heat using the power supplied from the power reception unit.
    Type: Application
    Filed: August 29, 2022
    Publication date: March 16, 2023
    Applicant: EVERWELL TECHNOLOGY CO., LTD
    Inventor: Su Nam YU
  • Patent number: 11498945
    Abstract: The present invention relates to an immunogenic fragment peptide of an EN2 protein or an antibody composition specifically recognizing the same. In the present invention, EN2 protein can be quantified through a method of specifically recognizing the peptide. Also, an antibody prepared using the peptide has vastly superior detection sensitivity compared to existing EN2 protein antibodies and thus can be useful in a diagnostic agent for diagnosing prostate cancer.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: November 15, 2022
    Assignee: Sung Kyun Biotech Co., Ltd.
    Inventors: Kyeong-Nam Yu, Eun-Yi Cho, Seung-Hee Chang, Seon-Hee Kim, Hyun-Suk Kim, Ki-Moon Park
  • Patent number: 11483900
    Abstract: A carbon felt heating device is disclosed. The carbon felt heating device includes a carbon felt unit adapted to radiate heat upon supply of power, and power-connecting portions, which are provided at two ends of the carbon felt unit so as to electrically connect the carbon felt unit to a power source, wherein at least some of voids in the carbon felt unit are filled with resin or polymer.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: October 25, 2022
    Assignee: EVERWELLTECHNOLOGY CO., LTD
    Inventors: Su Nam Yu, Se Hwan Jeong
  • Patent number: 11364201
    Abstract: The present invention relates to nano-liposome carrier compositions that encapsulate a hybrid of a Cas9 protein and a guide RNA and methods of making and using the same. The nano-liposome carrier compositions have an excellent effect of suppressing expression of target DNA, and thus pharmaceutical compositions including the nano-liposome carrier compositions can be used for treating diseases such as diabetes.
    Type: Grant
    Filed: June 12, 2019
    Date of Patent: June 21, 2022
    Inventor: Kyeong-Nam Yu
  • Patent number: 11337923
    Abstract: Provided are a nanoliposome-microbubble conjugate in which a drug for hair loss treatment such as finasteride, minoxidil, dutasteride, etc. is encapsulated in a nanoliposome and a composition for alleviating or treating hair loss containing the same. Since an orally administered agent such as finasteride, currently useful as a drug for hair loss treatment, causes side effects, drug delivery through scalp application is most desirable, but the drug is not delivered to hair follicle cells through scalp application alone. Since a drug for hair loss treatment useful as an external preparation for skin causes various side effects, the concentration thereof that is used needs to be further lowered. The above nanoliposome-microbubble conjugate is capable of increasing the delivery efficiency of a drug for hair loss treatment at a low concentration, and is thus very effective at treating androgenic alopecia.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: May 24, 2022
    Assignee: MOOGENE MEDI CO., LTD.
    Inventor: Kyeong Nam Yu
  • Publication number: 20220106368
    Abstract: The present invention relates to an immunogenic fragment peptide of an EN2 protein or an antibody composition specifically recognizing the same. In the present invention, EN2 protein can be quantified through a method of specifically recognizing the peptide. Also, an antibody prepared using the peptide has vastly superior detection sensitivity compared to existing EN2 protein antibodies and thus can be useful in a diagnostic agent for diagnosing prostate cancer.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 7, 2022
    Applicant: SUNG KYUN BIOTECH CO., LTD.
    Inventors: Kyeong-Nam YU, Eun-Yi CHO, Seung-Hee CHANG, Seon-Hee KIM, Hyun-Suk KIM, Ki-Moon PARK
  • Publication number: 20220106369
    Abstract: The present invention relates to an immunogenic fragment peptide of an EN2 protein or an antibody composition specifically recognizing the same. In the present invention, EN2 protein can be quantified through a method of specifically recognizing the peptide. Also, an antibody prepared using the peptide has vastly superior detection sensitivity compared to existing EN2 protein antibodies and thus can be useful in a diagnostic agent for diagnosing prostate cancer.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 7, 2022
    Applicant: SUNG KYUN BIOTECH CO., LTD.
    Inventors: Kyeong-Nam YU, Eun-Yi CHO, Seung-Hee CHANG, Seon-Hee KIM, Hyun-Suk KIM, Ki-Moon PARK
  • Publication number: 20220040104
    Abstract: Provided are a nanoliposome-microbubble conjugate in which a drug for hair loss treatment such as finasteride, minoxidil, dutasteride, etc. is encapsulated in a nanoliposome and a composition for alleviating or treating hair loss containing the same. Since an orally administered agent such as finasteride, currently useful as a drug for hair loss treatment, causes side effects, drug delivery through scalp application is most desirable, but the drug is not delivered to hair follicle cells through scalp application alone. Since a drug for hair loss treatment useful as an external preparation for skin causes various side effects, the concentration thereof that is used needs to be further lowered. The above nanoliposome-microbubble conjugate is capable of increasing the delivery efficiency of a drug for hair loss treatment at a low concentration, and is thus very effective at treating androgenic alopecia.
    Type: Application
    Filed: October 20, 2021
    Publication date: February 10, 2022
    Applicant: MOOGENE MEDI CO., LTD.
    Inventor: Kyeong Nam YU